← The Wire
AGENNasdaq
AGENUS INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1098972
AGENUS INC develops and seeks approval for product candidates, facing competition and market acceptance challenges
red 8-K · 90d
$137M
Market cap
$3.15
Last close
+4.0%
1D
+3.6%
5D
947K
Volume
Price · last 39 sessions-21.6%
May 4L $2.88 · H $4.17Jun 29
264
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 23, 20268-KExecutive ChangeMay 15, 2026DEFA14ADEFA14AMay 13, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEF 14ADEF 14AApr 30, 20268-KCompany UpdateMar 26, 202610-K10-KMar 16, 20268-KResults of OperationsMar 16, 2026SC 13DSC 13DJan 23, 20268-KAcquisition / Disposition · Equity IssuanceJan 16, 20268-KExecutive ChangeJan 14, 20268-KMaterial Agreement · Security-Holder RightsJan 8, 202610-Q10-QNov 10, 20258-KResults of OperationsNov 10, 20258-KMaterial Agreement · New Debt / ObligationOct 9, 20258-KCompany UpdateSep 23, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KShareholder VoteJun 20, 20258-KMaterial Agreement · Reg FD DisclosureJun 4, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEF 14ADEF 14AApr 30, 202510-K10-KMar 17, 20258-KResults of OperationsMar 11, 20258-KMaterial Agreement · New Debt / ObligationFeb 26, 20258-KAgreement TerminatedFeb 10, 20258-KExit / Disposal CostsDec 5, 20248-KMaterial Agreement · New Debt / ObligationNov 27, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-K/AExecutive ChangeNov 8, 2024SC 13GSC 13GNov 8, 20248-KExecutive ChangeNov 5, 2024SC 13GSC 13GOct 22, 20248-KExecutive Change · Results of OperationsAug 8, 2024424B5424B5Aug 8, 202410-Q10-QAug 8, 20248-KAgreement TerminatedAug 2, 20248-KExecutive ChangeJun 17, 20248-KShareholder VoteJun 14, 20248-KAcquisition / DispositionMay 30, 20248-KResults of OperationsMay 7, 202410-Q10-QMay 7, 20248-KMaterial Agreement · Equity IssuanceMay 7, 2024DEF 14ADEF 14AApr 26, 20248-KBylaw Amendment · Shareholder VoteApr 5, 202410-K10-KMar 14, 20248-KResults of OperationsMar 14, 2024DEFA14ADEFA14AFeb 29, 2024DEF 14ADEF 14AFeb 26, 2024SC 13GAGENUS INCFeb 21, 20248-KReg FD DisclosureFeb 15, 20248-KCompany UpdateJan 31, 20248-KDelisting NoticeDec 8, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 7, 20238-KExit / Disposal CostsAug 23, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 15, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEF 14ADEF 14AApr 28, 20238-KCompany UpdateApr 24, 20238-KCompany UpdateMar 30, 202310-K10-KMar 16, 20238-KResults of OperationsMar 14, 2023SC 13GSC 13GFeb 1, 20238-KExecutive ChangeDec 23, 20228-KMaterial Agreement · New Debt / ObligationDec 2, 20228-KResults of OperationsNov 8, 202210-Q10-QNov 8, 20228-KResults of OperationsAug 9, 202210-Q10-QAug 9, 20228-KBylaw Amendment · Shareholder VoteAug 5, 2022DEF 14ADEF 14AJun 22, 20228-KShareholder VoteJun 14, 20228-KResults of OperationsMay 10, 2022
Similar companies
Comparable business profile · signals at a glance